Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Mitoquinone mesylate (MitoQ)
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
Multi-component Interventions
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multi-component intervention package
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multistrain Probiotic
Ultragenyx UK Limited
Cystic Fibrosis in Children
1 trial -
Mupirocin
Hospital Authority, Hong Kong
Peritoneal Dialysis-related Infection
1 trial -
N-butyl-2-cyanoacrylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Varices
1 trial -
NO Ultra
Atrium Therapeutics
Hypertension
1 trial -
Naglazyme®
BioMarin Pharmaceutical Australia Pty Ltd
Maroteaux-Lamy Syndrome
1 trial -
NanoDOX 1% doxycycline monohydrate Hydrogel
United Therapeutics Europe Ltd
Dehisced Surgical Wounds
1 trial -
Neo-ASA
Ultragenyx UK Limited
Argininosuccinate Lyase Deficiency
1 trial -
Neomycin/ Dexameythasone/Xylometazoline
Biotech Pharmaceutical Co.,
Rhinosinusitis
1 trial -
New infant formula
United Therapeutics Europe Ltd
Functional Gastrointestinal Disorders
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Nicotinamide Riboside
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Nicotine Replacement
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
2 trials -
Nicotine replacement therapy sampling
United Therapeutics Europe Ltd
Smoking Cessation
1 trial -
Nitrate enriched beetroot juice
COGNITION THERAPEUTICS INC
Aging
1 trial -
Norepinephrine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypotension
1 trial -
Norepinephrine
Shanghai Zhongshan Hospital
Gastrointestinal Disease
1 trial -
Normal Saline (Placebo)
The First People's Hospital of Lianyungang
Disease of Respiratory System
1 trial -
Nutributter Program
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Nutrient supplement to pregnant women (PNS)
United Therapeutics Europe Ltd
Stunting in Under-2 Children
1 trial -
Nutrilite Protein MetX Pro
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources